Apogee Therapeutics (APGE) Other Non-Current Liabilities (2022 - 2026)
Apogee Therapeutics (APGE) reported Other Non-Current Liabilities of $600000.0 for Q1 2026, down 71.43% quarter-over-quarter from $2.1 million in Q4 2025.
Apogee Therapeutics (APGE) Other Non-Current Liabilities (2022 - 2026) Analysis & Trends
Apogee Therapeutics (APGE) has 5 years of Other Non-Current Liabilities data on file, last reported at $600000.0 in Q1 2026.
- Other Non-Current Liabilities for Q1 2026 came in at $600000.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $600000.0 (changed N/A YoY), and the FY2025 annual result was $2.1 million, up 2000.0% from the prior year.
- Other Non-Current Liabilities retreated to $600000.0 in Q1 2026 per APGE's latest filing, from $2.1 million in the prior quarter.
- Over five years, Other Non-Current Liabilities peaked at $8.0 million in Q4 2022 and troughed at $100000.0 in Q4 2024.
- A 5-year average of $3.0 million and a median of $2.1 million in 2025 frame the typical range for Other Non-Current Liabilities.
- The sharpest annual moves came in 2024 and 2025: Other Non-Current Liabilities plunged 98.08% in 2024, then jumped 2000.0% in 2025.
- A 5-year view of Other Non-Current Liabilities shows it stood at $8.0 million in 2022, then tumbled by 35.0% to $5.2 million in 2023, then sank by 98.08% to $100000.0 in 2024, then jumped by 2000.0% to $2.1 million in 2025, then plunged by 71.43% to $600000.0 in 2026.
- Business Quant data shows APGE's Other Non-Current Liabilities at $600000.0 in Q1 2026, $2.1 million in Q4 2025, and $100000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Apogee Therapeutics | 6.29 Bn | 5.23 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 600,000.00 |
| Dec 31, 2025 | 2.10 Mn |
| Jun 30, 2025 | 100,000.00 |
| Dec 31, 2024 | 100,000.00 |
| Sep 30, 2024 | 500,000.00 |
| Jun 30, 2024 | 1.20 Mn |
| Mar 31, 2024 | 2.50 Mn |
| Dec 31, 2023 | 5.20 Mn |
| Sep 30, 2023 | 6.60 Mn |
| Jun 30, 2023 | 5.90 Mn |
| Dec 31, 2022 | 8.00 Mn |